ArticleZeitschrift fur Rheumatologie2020
[RABBIT-SpA: a new disease register for axial spondyloarthritis and psoriatic arthritis].
Article in Zeitschrift fur Rheumatologie, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed.
- Depressive symptoms are associated with achieving remission in PsA patients - an analysis from the RABBIT-SpA register.BMC rheumatology · 2026Article
- Article
- Severe impairments in work ability among patients with axSpA and PsA: results from the RABBIT-SpA Register.RMD open · 2026Article
- Frequency of difficult-to-manage and treatment-refractory axial SpA: insights from the German RABBIT-SpA register using recent ASAS definitions.Rheumatology (Oxford, England) · 2026Article
- Real-world sex differences in treatment persistence and reasons for discontinuation in psoriatic arthritis patients: results from the German RABBIT-SpA register.Arthritis research & therapy · 2025Article
- Which are the clinical characteristics that lead to the decision of primary or secondary usage of TNFi or IL-17i in patients with axial spondyloarthritis?: Real-world evidence from the RABBIT-SpA cohort.EULAR rheumatology open · 2025Article
- Discordance between patient and physician reported global disease activity in PsA is associated with mental health-a cross-sectional analysis.Rheumatology international · 2025Article
- Effect of depressive symptoms on treatment response in patients with axSpA: data from the RABBIT-SpA register.RMD open · 2025Observational
- Article
- Recording of non-musculoskeletal manifestations, comorbidities and safety outcomes in European spondyloarthritis registries: a survey.Rheumatology advances in practice · 2024Article
- Depressive symptoms are associated with fatigue, poorer functional status and less engagement in sports in axSpA and PsA: an analysis from the RABBIT-SpA cohort.Arthritis research & therapy · 2023Article
- Comparison of patients with axial PsA and patients with axSpA and concomitant psoriasis: an analysis of the German register RABBIT-SpA.RMD open · 2023Article
- [Development of quality standards for patients with axial spondyloarthritis for use in Germany].Zeitschrift fur Rheumatologie · 2022Article
- Implementing an automated monitoring process in a digital, longitudinal observational cohort study.Arthritis research & therapy · 2021Observational
- [Register and cohort studies : Overview of the most important data sources at the German Rheumatism Research Center].Zeitschrift fur Rheumatologie · 2020Review
- [Perspectives for rheumatological health services research at the German Rheumatism Research Center].Zeitschrift fur Rheumatologie · 2020Review
- Reality of care for musculoskeletal diseases at the population level : Results of the PROCLAIR collaborative project.Zeitschrift fur Rheumatologie · 2019Review
- [Reality of care for musculoskeletal diseases at the population level : Results of the PROCLAIR collaborative project. German version].Zeitschrift fur Rheumatologie · 2019Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe treatment of axial spondyloarthritis (axSpA) and psoriatic arthritis (PsA) has changed enormously in recent years due to market authorization of a number of new biologicals with different modes of action and the increasing use of biosimilars. Real-world data on long-term safety and efficacy under routine daily conditions is not yet sufficient. Therefore, the German Rheumatism Research Center has initiated a new cohort study covering axSpA and PsA.
objectivePresentation of initial results from the new register RABBIT-SpA, which was started in May 2017. MATERIAL AND
methodsThis is a prospective longitudinal cohort study with a similar study design to the German biologics register RABBIT. Patients can be included at the start of a new treatment either in the so-called index drug group or in the comparison group (conventional systemic treatment, including non-steroidal anti-inflammatory drugs, NSAID). Follow-up per patient should be at least 5 years and preferably 10 years. The RABBIT-SpA uses a web-based documentation system.
resultsUp to mid-December 2018 a total of 514 axSpA patients had been documented in RABBIT-SpA, 410 with an index drug and 104 with conventional treatment. There are differences between these treatment groups, e. g. in the duration of the disease and in parameters of disease activity. It is also noticeable that in axSpA patients, approximately 5 years lie between the onset of the symptoms and confirmation of the diagnosis. Of the 355 PsA patients, 265 were included with an index drug and 90 with conventional treatment. Of the PsA patients 86% have a dominant peripheral manifestation. The average number of pressure tender joints is 8 and the average number of swollen joints is 4.
conclusionThe online register RABBIT-SpA is well-received by the participating rheumatological institutions. The electronic recording of patient data can be carried out in a reasonable time. Participation in the RABBIT-SpA is open to new rheumatological institutions at any time.
Indexed as
Identifiers
30874933What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.